* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download 1 - Wk 1-2
Gluten immunochemistry wikipedia , lookup
Vaccination wikipedia , lookup
Anti-nuclear antibody wikipedia , lookup
Sjögren syndrome wikipedia , lookup
Molecular mimicry wikipedia , lookup
Hygiene hypothesis wikipedia , lookup
Adoptive cell transfer wikipedia , lookup
Immune system wikipedia , lookup
Immunocontraception wikipedia , lookup
Social immunity wikipedia , lookup
Adaptive immune system wikipedia , lookup
Monoclonal antibody wikipedia , lookup
Herd immunity wikipedia , lookup
Cancer immunotherapy wikipedia , lookup
Psychoneuroimmunology wikipedia , lookup
X-linked severe combined immunodeficiency wikipedia , lookup
Innate immune system wikipedia , lookup
Polyclonal B cell response wikipedia , lookup
1. Identify non-immune barriers to infection including the epithelial barrier function of skin and gastrointestinal system, the acid bath of the stomach, antibacterial enzymes in secretions. Epithelial barrier function of skin and gastrointestinal system - Stratified Squamous Keratinizing epithelia of skin, desmosomes which lock cells together (keratin creates are hard protective layer and the desmosomes keep the cells tightly connected) - Sero-mucous surfaces inhibit adherence to epithelial cells- antibacterial tears, respiratory mucociliary escalator. Acid Bath of the stomach - Acid pH of stomach and the digestive enzymes, bile salts, fatty acids and lysolipids found in the upper gastrointestinal tract create a substantial chemical barrier to infection Antibacterial enzymes in secretions - Lactic acid and fatty acids in sweat and sebaceous secretions lower pH - Stomach, skin and vaginal acid secretions have an antibacterial effect - Other secretions that have with antimicrobial action o lysozyme and phospholipase A in tears and saliva, o saliva also contains histatins (histadine-rich peptides with antimicrobial properities) o lactoperoxidase in milk, o acid in gastric juice, o spermine and zinc in semen 2. Distinguish passive versus active immunity, including maternal IgG in the neonate. There are 2 ways of achieving immunity: Active immunization Passive immunization These may be naturally acquired or artificially induced Active Immunity: Exposure to immunogenic stimulus triggers immune response by host. Artificially acquired active immunity: Can be induced by a vaccine, a substance that contains the antigen. A vaccine stimulates a primary response against the antigen without causing symptoms of the disease. The vaccine can contain live organisms, inactivated organisms (attenuated) or their toxins. Slow effects, but long lived. Artificially acquired passive immunity: A short-term immunization by the injection of antibodies, such as gamma globulin, that are not produced by the recipient's cells. Antibodies may be given as: Human normal immunoglobulin (prepared from random pools of donated blood), containing Ab’s to diseases prevalent in community, OR Human specific immunoglobulin prepared from convalescent individuals with high titre Ab’s to particular organism (hyperimmune immunoglobulin) Fast effects, but short lived. Naturally acquired active immunity: Occurs when the person is exposed to a live pathogen, develops the disease, and becomes immune as a result of the primary immune response. Naturally acquired passive immunity: Occurs during pregnancy, in which certain antibodies are passed from the maternal into the foetal bloodstream. Of the three main immunoglobulins, IgG, IgA and IgM, only IgG is small enough to cross the placental barrier. It affords immunity to specific viral infections. At birth the baby's levels of IgG are equal to or slightly higher than those of the mother. This provides passive immunity during the first few months of life. Passive immunity is short lived because these IgG Ab’s gradually catabolised (t1/2 = 3 weeks), so protection only lasts ~4 months. 3. Identify the role of cell-mediated immunity, antibodies and complement in defence. Humoral immunity, also called antibody-mediated immunity, is provided by antibodies present in the body’s “humors,” or fluids (blood, lymph, etc.). Though they are produced by lymphocytes (or their offspring), antibodies circulate freely in the blood and lymph, where they bind primarily to bacteria, to bacterial toxins, and to free viruses, inactivating them temporarily and marking them for destruction by phagocytes or complement. Antibodies are fairly useless against infectious microorganisms like viruses and the tuberculosis bacillus that quickly slip inside body cells to multiply there. When lymphocytes themselves rather than antibodies defend the body, the immunity is called cell-mediated immunity or cellular immunity because the protective factor is living cells. In cases where antibodies provide only partial immunity, cell-mediated arm of immunity comes into play. Cell mediated Immunity refers to the removal or destruction of pathogens, cells infected by viruses, intracellular bacteria as well as abnormal or cancerous cells by T lymphocytes, mf, NK cells, neutrophils. Complement System The term complement system, or simply complement, refers to a group of at least 20 plasma proteins that normally circulate in the blood in an inactive state. These proteins include C1 through C9, factors B, D, and P, plus several regulatory proteins. Complement provides a major mechanism for destroying foreign substances in the body. Its activation unleashes chemical mediators that amplify virtually all aspects of the inflammatory process. Another effect of complement activation is that certain bacteria and other cell types are killed by cell lysis. (Luckily our own cells are equipped with proteins that inactivate complement.) Although complement is a nonspecific defensive mechanism, it “complements” (enhances) the effectiveness of both innate and adaptive defenses. The complement is activated via 3 pathways. Complement can be activated by the two pathways outlined in Figure 21.6. The classical pathway involves antibodies, water-soluble protein molecules that the adaptive immune system produces to fight off foreign invaders. The classical pathway depends on the binding of antibodies to the invading organisms and the subsequent binding of C1 to the microorganism-antibody complexes, a step called complement fixation (described). The alternative pathway is triggered when factors B, D, and P interact with polysaccharide molecules present on the surface of certain microorganisms. Complement activation by either pathway involves a cascade in which proteins are activated in an orderly sequence—each step catalyzing the next. The two pathways converge on C3, cleaving it into C3a and C3b. This event initiates a common terminal pathway that causes cell lysis, promotes phagocytosis, and enhances inflammation. The lytic events begin when C3b binds to the target cell’s surface, triggering the insertion of a group of complement proteins called MAC (membrane attack complex) into the cell’s membrane. MAC forms and stabilizes a hole in the membrane that ensures lysis of the target cell by inducing a massive influx of water. The C3b molecules that coat the microorganism provide “handles” that receptors on macrophages and neutrophils can adhere to, allowing them to engulf the particle more rapidly. As noted earlier, this process is called opsonization. C3a and other cleavage products formed during complement fixation amplify the inflammatory response by stimulating mast cells and basophils to release histamine and by attracting neutrophils and other inflammatory cells to the area. 4. Indicate a broad classification of immunodeficiency syndromes, based upon the functions of the major elements of the immune system. Primary immunodeficiency (almost always genetic) is classified into five main groups depending on which element of the immune system is deficient. Affects specific and innate responses. Usually manifest between 6 months to 2 years with susceptibility to recurrent infections, pathogens causing infections give clues to which part of the system is lacking. 1. B-lymphocyte deficiency: low levels of antibody is results in inability to clear extracellular bacteria 2. T-lymphocyte deficiency: both cell-mediated and humoral immunity fail thus hard to distinguish from B and T cell deficiency (SCID) 3. Both B & T-lymphocyte deficiency both cell-mediated and humoral immunity fail 4. Phagocytic disorders: permit widespread bacterial infections 5. Complement disorders: defective humoral immune function and persistence of immune complexes (eg membrane attack complex of complement). Secondary immunodeficiency is an impairment of the immune system resulting from complications from an illness/infection, malnutrition, aging, or side effects from immunosuppression, irradiation or chemotherapy for cancer and other autoimmune diseases in a previously normal person. The impairment may or may not be reversible if the underlying condition or illness is rectified. Secondary deficiency is more common than primary. 1. Hereditary and metabolic disease – chromosome abnormalities 2. Immunosuppressive agents – corticosteroids, radiation, immunosuppressive drugs 3. Infectious disease – HIV/AIDS 4. Infiltrative and haematological disease – Leukaemia(Progressive proliferation of abnormal leukocytes), lymphoma, agranulocytosis, aplastic anaemia. 5. Surgery and Trauma – burns, splenectomy, anaesthesia SCID (Severe Combined Immunodeficiency Disease) Absence of both humoral (antibody) and cellular immunity with alymphoplasia or lymphopenia (both B-type and T-type lymphocytes), associated with marked susceptibility to infection by bacteria, fungi, protozoa, and viruses, and to progressive disease from live vaccines. Death occurs usually before the end of the first year of life, although bone marrow transplants have been effective in extending life; SCID can be inherited as either autosomal recessive however there is also an X-linked severe combined immunodeficiency with a major histocompatability class I and/or class II deficiency. Suffer recurrent infections early in life including: Prolonged diarrhoea (rotavirus), pneumonia (Pneumocystis carinii), oral candidiasis. In ADA deficiency and receptor mutation (ie the 2 most common types of SCID), the thymus is small and devoid of lymphoid cells, or absent. Hypogammaglobulinaemia and failure of antibody production (will see maternal IgG in infants). Very low or absent T (CD3) cells; normal NK (CD16) cells B lymphocytes are usually present (with surface IgM) Treatment is a bone marrow transplant.